Primary |
Crohn's Disease |
31.7% |
Colitis Ulcerative |
12.2% |
Product Used For Unknown Indication |
11.7% |
Drug Use For Unknown Indication |
8.9% |
Rheumatoid Arthritis |
5.0% |
Immunosuppressant Drug Therapy |
4.4% |
Immunosuppression |
3.9% |
Idiopathic Pulmonary Fibrosis |
3.3% |
Myasthenia Gravis |
3.3% |
Renal Transplant |
2.8% |
Autoimmune Hepatitis |
2.2% |
Multiple Sclerosis |
2.2% |
Colitis |
1.7% |
Interstitial Lung Disease |
1.1% |
Juvenile Arthritis |
1.1% |
Pemphigoid |
1.1% |
Relapsing-remitting Multiple Sclerosis |
1.1% |
Systemic Lupus Erythematosus |
1.1% |
Antifungal Prophylaxis |
0.6% |
Antiviral Prophylaxis |
0.6% |
|
Pancreatitis |
16.7% |
Vomiting |
13.0% |
Weight Decreased |
7.4% |
Pancreatitis Acute |
5.6% |
Pyrexia |
5.6% |
Sepsis |
5.6% |
Wrong Drug Administered |
5.6% |
Pneumonia Viral |
3.7% |
Rash |
3.7% |
Renal Failure Chronic |
3.7% |
Respiratory Failure |
3.7% |
Squamous Cell Carcinoma |
3.7% |
Subarachnoid Haemorrhage |
3.7% |
Thrombosis |
3.7% |
Transplant Failure |
3.7% |
White Blood Cell Count Increased |
3.7% |
Acidosis |
1.9% |
Acute Febrile Neutrophilic Dermatosis |
1.9% |
Acute Myeloid Leukaemia |
1.9% |
Anaphylactic Shock |
1.9% |
|
Secondary |
Crohn's Disease |
34.8% |
Product Used For Unknown Indication |
12.4% |
Colitis Ulcerative |
12.3% |
Drug Use For Unknown Indication |
11.4% |
Rheumatoid Arthritis |
5.5% |
Behcet's Syndrome |
4.5% |
Lung Transplant |
2.5% |
Colitis |
1.9% |
Hypertension |
1.8% |
Renal Transplant |
1.7% |
Heart Transplant |
1.5% |
Osteoporosis |
1.5% |
Asthma |
1.3% |
Inflammatory Bowel Disease |
1.2% |
Systemic Lupus Erythematosus |
1.1% |
Prophylaxis |
1.0% |
Juvenile Arthritis |
1.0% |
Depression |
0.9% |
Idiopathic Thrombocytopenic Purpura |
0.8% |
Pain |
0.8% |
|
White Blood Cell Count Decreased |
11.3% |
Tumour Lysis Syndrome |
8.7% |
Vomiting |
7.5% |
Pancreatitis |
7.2% |
Weight Decreased |
6.4% |
Hepatosplenic T-cell Lymphoma |
5.5% |
Pneumonia |
5.5% |
Pyrexia |
5.5% |
Tonsillitis |
5.2% |
White Blood Cell Count Increased |
5.2% |
Liver Disorder |
4.1% |
Pancytopenia |
3.8% |
T-cell Lymphoma |
3.8% |
Lymphoma |
3.2% |
Sepsis |
3.2% |
Pancreatitis Acute |
2.9% |
Pulmonary Embolism |
2.9% |
Rash |
2.9% |
Anaemia |
2.6% |
Crohn's Disease |
2.6% |
|
Concomitant |
Crohn's Disease |
32.6% |
Product Used For Unknown Indication |
23.6% |
Colitis Ulcerative |
10.3% |
Drug Use For Unknown Indication |
6.4% |
Rheumatoid Arthritis |
5.5% |
Pain |
2.6% |
Hypertension |
2.6% |
Osteoporosis |
2.0% |
Depression |
1.9% |
Premedication |
1.7% |
Prophylaxis |
1.5% |
Gastrooesophageal Reflux Disease |
1.5% |
Vitamin Supplementation |
1.2% |
Systemic Lupus Erythematosus |
1.2% |
Insomnia |
1.0% |
Anxiety |
1.0% |
Nausea |
0.9% |
Diabetes Mellitus |
0.9% |
Blood Cholesterol Increased |
0.8% |
Medical Diet |
0.8% |
|
Vomiting |
12.7% |
Injection Site Pain |
9.7% |
Weight Decreased |
9.7% |
Pyrexia |
7.9% |
Colitis Ulcerative |
4.7% |
Crohn's Disease |
4.2% |
Nausea |
4.2% |
Pain |
4.2% |
Urinary Tract Infection |
4.1% |
Drug Ineffective |
4.0% |
Herpes Zoster |
4.0% |
Fatigue |
3.7% |
Diarrhoea |
3.6% |
Fistula |
3.6% |
Weight Increased |
3.6% |
Sinusitis |
3.4% |
Vision Blurred |
3.4% |
Headache |
3.1% |
Nephrolithiasis |
3.1% |
Pneumonia |
3.1% |
|
Interacting |
Liver Transplant Rejection |
16.1% |
Product Used For Unknown Indication |
16.1% |
Infection |
9.7% |
Crohn's Disease |
8.1% |
Colitis Ulcerative |
6.5% |
Prophylaxis Against Transplant Rejection |
6.5% |
Epilepsy |
4.8% |
Multiple Sclerosis |
4.8% |
Allergic Granulomatous Angiitis |
3.2% |
Asthma |
3.2% |
Breast Cancer Stage I |
3.2% |
Cardiac Failure |
3.2% |
Gastrooesophageal Reflux Disease |
3.2% |
Gout |
3.2% |
Hypercholesterolaemia |
3.2% |
Hyperuricaemia |
3.2% |
Infection Prophylaxis |
1.6% |
|
Drug Interaction |
16.7% |
Meningitis Cryptococcal |
16.7% |
Agitation |
8.3% |
Alopecia |
8.3% |
Diplopia |
8.3% |
Dizziness |
8.3% |
Drug Intolerance |
8.3% |
Influenza Like Illness |
8.3% |
Overdose |
8.3% |
Tremor |
8.3% |
|